Sara Bonstein, Chief Financial Officer at INSMED Inc (INSM), sold 115,530 shares at $102.15 ($11.8M) on 2025-06-23, disclosed to the SEC on 2025-06-25.
Scheduled sale ($11.8M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $101.71 | 49,104 | $5.0M | 42.5% |
| 2 | $101.71 | 49,104 | $5.0M | 42.5% |
| 3 | $102.15 | 8,661 | $885K | 7.5% |
| 4 | $102.15 | 8,661 | $885K | 7.5% |
| Total | $101.78 avg | 115,530 | $11.8M | 100% |
| Filing → |
| INSM | SELL | 2026-02-04 | $117K | — | Filing → |
| INSM | SELL | 2026-01-08 | $809K | — | Filing → |
| INSM | SELL | 2025-07-23 | $12.0M | — | Filing → |